Novartis hits targets in late-stage QMF149 asthma trial
The once-daily, fixed-dose treatment demonstrated significant improvements in lung function and asthma control.
Read More
Author: Anna Smith
BMJ study shows correlation between processed foods and CV disease
Cardiovascular disease is the main cause of death worldwide, representing one third of all deaths globally.
Read More
NICE issues guidance revision for depression
The governing body has been urged to undergo a “full and proper revision” of its 2009 guideline on adult depression.
Read More
Milestone achieved in J&J’s investigational HIV study
Johnson & Johnson has announced full enrolment in its proof-of-concept efficacy study of Imbokodo.
Read More
NHS to launch new online type II diabetes support
The new online portal will offer people with type II diabetes evidence-based information and support.
Read More- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
- FDA approves once‑weekly Sogroya for wider paediatric use
- SolasCure trial shows faster healing with Aurase Wound Gel
